01 LANREOTIDE ACETATE (3)
01 IPSEN PHARMA (3)
01 SOLUTION;SUBCUTANEOUS (3)
01 EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) (1)
02 EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) (1)
03 EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) (1)
01 USA (3)
19
Ipsen, based in France, is a pharmaceutical company.
One of their notable products is LANREOTIDE ACETATE, with a corresponding application number 22074 and regulatory information .
proudly manufactured in the
approval since 2007-08-30
Ipsen's SOMATULINE DEPOT SOLUTION;SUBCUTANEOUS, medication with EQ 60MG BASE/0.2ML (EQ 60MG BASE/0.2ML) of LANREOTIDE ACETATE.
18
Ipsen, based in France, is a pharmaceutical company.
One of their notable products is LANREOTIDE ACETATE, with a corresponding application number 22074 and regulatory information .
proudly manufactured in the
approval since 2007-08-30
Ipsen's SOMATULINE DEPOT SOLUTION;SUBCUTANEOUS, medication with EQ 90MG BASE/0.3ML (EQ 90MG BASE/0.3ML) of LANREOTIDE ACETATE.
17
Ipsen, based in France, is a pharmaceutical company.
One of their notable products is LANREOTIDE ACETATE, with a corresponding application number 22074 and regulatory information .
proudly manufactured in the
approval since 2007-08-30
Ipsen's SOMATULINE DEPOT SOLUTION;SUBCUTANEOUS, medication with EQ 120MG BASE/0.5ML (EQ 120MG BASE/0.5ML) of LANREOTIDE ACETATE.